Cuban said the high fees the FDA charges to approve generic drugs are a major barrier to manufacturing lower-priced generics in the United States, according to the report. Cuban said Cost Plus Drugs, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results